2005-07-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/701565Efficacy and Safety of DCB-AD1 in Alzheimer Disease---A 24 Weeks Multi-Center, Double-Blind, Placebo-Controlled Therapeutic Trial